Open-source, fully automated framework for end-to-end aortic analysis from CT angiography (CTA), built on top of TotalSegmentator baseline segmentations with additional refinement. AortaExplorer extracts established biomarkers such as diameters across anatomical segments defined by the European Society of Cardiology, and introduces new metrics including aortic tortuosity. Diameter measurements were validated against expert manual readings in more than 10,000 CTA scans from Danish population cohorts, and the tortuosity index's increase with age is consistent with prior literature; the tool reduces per-case analysis time from about 15 minutes to under 5 minutes.

Regression-based convolutional neural network that directly estimates the heart-rate-corrected QT interval (QTc) from a 12-lead ECG, aiming to improve on automated QTc measurements from commercial ECG systems, which often diverge from expert readings. QTcNet was trained on 120,300 algorithm-labeled ECGs from an internal hospital cohort and the public MIMIC-IV database (after correcting for a vendor-specific measurement bias), and evaluated against expert QTc measurements in three independent external cohorts (PTB Diagnostic ECG Database, QTcMS, and ECGRDVQ). It roughly halved the mean absolute error compared with standard ECG analysis software (from 23.4ms to 13.4ms across external validation cohorts), with explainability analysis confirming the model focuses on physiologically plausible QRS-onset and T-offset regions.

Deep-learning model that estimates a patient's 10-year risk of major adverse cardiovascular events (MACE) directly from a single routine chest radiograph (CXR), intended as an opportunistic risk-assessment tool when the inputs needed for the standard ASCVD risk calculator (lipids, blood pressure, smoking status, etc.) are missing. A 2D convolutional network takes the CXR image alone as input and outputs a continuous 10-year MACE risk estimate. Developed on 147,801 CXRs from 40,718 participants in the PLCO cancer-screening trial and externally validated in 8,869 outpatients with unknown ASCVD risk and 2,132 with known risk at Mass General Brigham, CXR CVD-Risk identified people at elevated MACE risk (adjusted hazard ratio 1.73 for a >=7.5% predicted risk) and provided added discrimination beyond the traditional ASCVD score.

Open, transparent deep-learning method for measuring left ventricular global longitudinal strain (GLS) from routine 2D echocardiography, built as an alternative to proprietary vendor strain software. Unity-GLS is a multi-image neural network (based on the HigherHRNet-W32 pose-estimation architecture) that identifies the mitral annulus, LV apex, and endocardial curve from a target frame plus six neighbouring frames, across apical 4-, 3-, and 2-chamber views. Validated against multi-expert (11-reader) consensus tracings from 100 echocardiograms in a UK-wide collaborative, Unity-GLS agreed with expert consensus as strongly as individual human experts and two proprietary vendor packages (correlation with consensus: 0.91 vs. 0.73-0.85 for other methods).

Multi-outcome AI-ECG risk-estimation platform that turns a single 12-lead ECG into a patient-specific survival curve, using a residual convolutional neural network trained with a discrete-time survival loss to predict not just risk but time-to-event. Beyond all-cause and cardiovascular mortality, separately fine-tuned heads predict future ventricular arrhythmia, complete heart block, atrial fibrillation, atherosclerotic cardiovascular disease, heart failure, and (in follow-up work) hypertension -- all from a single resting ECG, including in ECGs a cardiologist would read as normal. Derived on 1.16 million ECGs from 189,539 Beth Israel Deaconess Medical Center patients and externally validated across transnational cohorts in the USA, Brazil (CODE), and the UK (UK Biobank). A variational autoencoder and genome/phenome-wide association analyses were used to show the model's predictions track biologically plausible features (QRS morphology, LV structure/function, and loci linked to cardiac structure, QT interval, and biological aging). NHS trials of AIRE were planned for late 2025. No public code or model weights have been released.

ECG-guided photoplethysmography (PPG) foundation model pretrained on over 100,000 hours of synchronized PPG-ECG recordings from 58,796 subjects across five clinical and wearable sources, using a CLIP-style contrastive alignment framework so the PPG encoder inherits physiologically grounded structure from paired ECG. Achieves state-of-the-art performance on 13 of 15 conventional physiological-analysis tasks across eight datasets, and shows meaningful discriminative capability (AUC >= 0.70) for 307 ICD-10-coded phenotypes across 16 phecode chapters, including many non-cardiovascular conditions.

Self-supervised foundation model for photoplethysmography (PPG) that explicitly targets the low-signal-quality problem endemic to real-world wearable and bedside PPG, rather than assuming clean input. A Siamese ResNet (SimSiam-style) encoder is pretrained to produce similar representations for temporally-adjacent high- and low-quality PPG segments presumed to share the same underlying physiological state, with curriculum learning that gradually increases the artifact-level gap between paired segments. Pretrained on over 36 million 30-second PPG pairs drawn from more than 24,100 UCSF ICU patients, then fine-tuned and evaluated on six downstream cardiovascular-monitoring datasets/tasks (heart rate, respiratory rate, blood pressure, and atrial-fibrillation detection), where it exceeds prior state-of-the-art by roughly 75% on respiratory-rate estimation and 5% on AF detection, with performance scaling with backbone depth (ResNet152 best). Code and the pretraining dataset are not public; the pretraining data is available upon request under a UCSF-Emory data use agreement.

Video-based deep learning model that estimates 14 common blood biomarkers and laboratory values—including hemoglobin (anemia), B-type natriuretic peptide (BNP), troponin I, and blood urea nitrogen (BUN)—directly from apical-4-chamber echocardiogram videos. Built on a spatiotemporal convolutional network (R(2+1)D-style) with residual connections that produces beat-by-beat estimates for both regression and abnormality classification. Trained on over 70,000 echocardiograms from Stanford Healthcare and externally validated at Cedars-Sinai, reaching AUCs around 0.80–0.86 for detecting anemia and elevated BNP. Developed by the Ouyang and Zou labs at Stanford University and Cedars-Sinai.

1D residual neural network that predicts a patient's age directly from a 12-lead ECG; the gap between this predicted 'ECG age' and true chronological age is used as a biomarker of cardiovascular risk and mortality. Trained on the CODE-15% Brazilian ECG dataset, with the original R² of 0.71 later reproduced (R² = 0.70) in an independent German validation cohort. Developed by researchers at Uppsala University and UFMG.

Predicts a patient's age from echocardiogram videos across four standard views (PLAX, A2C, A4C, and subcostal), trained on a private multi-site cohort of over 2.6 million videos from more than 166,000 studies across roughly 90,000 patients. The gap between this AI-predicted age and true chronological age is studied as a marker of accelerated or delayed cardiovascular aging and its relationship to all-cause mortality. Uses a 3D CNN (R(2+1)D) with a separate pretrained model per view. Developed by Cedars-Sinai Medical Center and Stanford's Ouyang lab.

Translates a raw PPG waveform into a full continuous arterial blood-pressure waveform, from which systolic, diastolic, and mean arterial pressure are derived. Uses a two-stage cascaded 1D convolutional network in a U-Net style, with a coarse approximation stage followed by a refinement stage. Meets BHS Grade A and AAMI accuracy standards for diastolic and mean arterial pressure. Developed at BUET.